*Hiroshi Ichinose1, Rina Aida1, Yuka Nago-Iwashita1, Yuki Moriya2, Soichiro Ide2, Kazutaka Ikeda2 (1. School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan, 2. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)
Session information
[CINP2024] Featured Communications
CINP2024 » Featured Communications
Featured Communications 6
Sun. May 26, 2024 2:50 PM - 4:10 PM Room 3 (Hall D7)
Chair: Stefano Comai (University of Padova)
*Lih-Chu Chiou1,2, Chia-Chi Lu1, Hsin-Jung Lee1, Akihiro Mouri3, Dishary Sharmin5, James Cook5, Toshitaka Nabeshima4 (1. Graduate Institutue of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2. Graduate Institutue of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Graduate School of Health Sciences, Fujita Health University, Toyoake, Japan, 4. Laboratory of Health and Medical Science Innovation, Graduate School of Health Sciences, Fujita Health University, Toyoake, Japan, 5. Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.)
Atea Shkodra2, Benedetta Barzon1, Laura Cherchi2, Carolina Giulia Ferroni2, Sofia Nasini1, Danilo De Gregorio2, Paola Fadda3, Pasquale Paribello3, Mirko Manchia3, Alessio Squassina3, Claudia Pisanu3, Marta Bosia2, *Stefano Comai1 (1. University of Padua, 2. IRCCS San Raffaele Hospital, 3. University of Cagliari)
*Zijun Wang1, Yunwanbin Wang1, Shuwen Yue1, Fengwei Yang2,3, Archana Singh1 (1. University of Kansas, 2. University of Kansas Medical Center, 3. The Kansas Department of Health and Environment )